Preclinical Toxicology Study Software: Custom Build vs Off the Shelf
Buy. If you run conventional acute, repeat dose and safety pharmacology designs on one or two species, Instem Provantis or Xybion Pristima will cost you less than anything custom and arrives already validated.
On this page
Buy. If you run conventional acute, repeat dose and safety pharmacology designs on one or two species, Instem Provantis or Xybion Pristima will cost you less than anything custom and arrives already validated. Build only when study design variety, pathology peer review and named user licensing have turned your validated system into a place where data is retyped after the fact.
What the off the shelf products actually do well
You have a quote from Instem for Provantis, a quote from Xybion for Pristima, and someone in the room has said the words build our own. Be fair to the products first, because the buy case here is stronger than most laboratories admit out loud.
Provantis and Pristima both model a study as a real object rather than a folder: groups, doses, routes, collection schedules, in-life observations, clinical pathology, necropsy, histopathology and report tables. Both carry long regulatory track records, and that track record is worth money the first time a sponsor auditor asks what system holds your raw data. LabWare and comparable laboratory information management system (LIMS) products cover analytical and clinical pathology work properly. Instem also sells conversion tooling for the Standard for Exchange of Nonclinical Data (SEND), which you should price on its own before you assume a build has to include it.
Buy if your work looks like this. Conventional acute, repeat dose and safety pharmacology designs. One or two species. Analysers the vendor already supports. Sponsors who accept the vendor report format. Under roughly 60 Good Laboratory Practice (GLP) studies a year. A validated commercial system reaches your floor faster and cheaper than anything we can build, and the installation and operational qualification package comes with it instead of being a workstream you fund yourself. Most laboratories reading this sit exactly there, and we say so before we quote.
Where they stop: design variety and pathology peer review
The thing that breaks a packaged toxicology system is not volume. It is shape.
Dose escalation with interim decision points, satellite toxicokinetic groups on staggered bleed schedules, recovery cohorts, juvenile and reproductive designs, large animal work with individual handling, and device studies with implantation timepoints all stretch a fixed study design model. Each unusual design becomes a vendor configuration change request with a quotation and a lead time. The study starts before the configuration lands, so body weights go into a spreadsheet and someone keys them in afterwards. That transcription is the finding. Under 21 CFR Part 58 and the OECD principles of good laboratory practice a study has to be reconstructable from raw data, and a transcribed value creates two records where only one of them is raw. If the paper says 312 and the system says 342, no amount of downstream statistics fixes the study.
The second wall is pathology. Macroscopic and microscopic findings are graded judgements that have to be traceable to the pathologist who made them, against controlled terminology rather than free text, because free text makes incidence tables impossible to compute across studies. Peer review, where a second pathologist reviews a proportion of slides and disagreements are documented and resolved, is a workflow with its own record requirements and it is the part most systems skip. Legacy products predate whole slide imaging, so a scan is an attachment and the reviewer cannot see the region the pathologist saw.
The third is instruments. A digital pathology scanner, a telemetry system, an ophthalmology imaging device or a plate reader bought after your system was configured is an interface priced per device, and contract laboratories feel this hardest because every sponsor arrives with different expectations.
The arithmetic: named user licences versus a build
Nobody publishes pricing in this category, so use the number on your own quote rather than a figure from a comparison site. Then count named users honestly, which almost nobody does at quote stage. Study directors. In-life technicians on every shift, not just the day shift. Clinical pathology staff. Pathologists and their peer reviewers, including the contract pathologist who reads two studies a year. Quality assurance. Report writers. Archivists. Sponsor contacts who need read access during a study.
Work it two ways. Per user: if your quote lands near $2,000 per named user per year and the honest headcount is 45 rather than the 20 you scoped, the licence line is $90,000 a year before the annual support percentage and before per interface charges. Per study: a laboratory running 150 studies against that licence is paying about $600 a study for software, which is excellent value, and no build catches it on licence cost alone. A laboratory running 30 studies against the same licence is paying $3,000 a study.
That is why the crossover here is a headcount rather than a volume. In the laboratories we have costed this for, the licence line passes the amortised cost of a build somewhere between 40 and 55 named users, and it passes it sooner if your vendor charges separately for each analyser interface. Volume works against the build case, because a hundred studies of the same shape are exactly what a product is good at. Variety and headcount work for it.
What a custom build actually costs
From Digital Heroes delivery experience in regulated study capture, a first release covering study design as data, in-life scheduling, point of collection capture that works with no network in a barrier room, balance and barcode connections, and a write once audit trail with electronic signature under 21 CFR Part 11 runs $90,000 to $180,000 and ships in 16 to 22 weeks. A full platform adding clinical pathology import, necropsy and histopathology with controlled terminology, peer review, statistics, report assembly and SEND dataset generation runs $250,000 to $600,000 phased across 10 to 18 months.
Three lines are usually missing from the comparison you were shown. Computer system validation is its own workstream with its own documentation and test evidence, and it adds twenty to thirty percent to a regulated build rather than being absorbed into it. Data migration runs 10 to 25 percent of the build cost, and in this domain the honest work is deciding which historical studies genuinely need to live in the new system and which stay archived where they are. Year two support and enhancement runs 15 to 20 percent of build cost annually if you want a partner reachable while a study is in-life.
Two smaller lines are worth naming because they arrive after the invoice. Infrastructure sits at a few hundred dollars a month and is driven by image and document storage rather than compute, and it grows every year because nonclinical records have to stay producible long after the study closes. And every new analyser model you buy is an interface, whether you built the system or bought it, so do not price that as a saving on either side of the comparison.
What keeps the number down is a first release scoped to one study type you run repeatedly, one species, and only the instruments already on your floor.
The four situations where building wins
Regulatory fit. Your submissions depend on SEND datasets that have to pass validation before an electronic submission is accepted, and today they are reconstructed from spreadsheets and a Word report after the fact. Generating datasets and report tables from the same records, with the data definition file produced alongside them, is a build decision because it is a data model decision.
Scale economics. Named user licensing punishes shift work. A contract research organisation with three shifts of in-life technicians pays three times for the same bench, and the fee scales with exactly the growth you are trying to fund.
A workflow that is your competitive advantage. If sponsors choose you because you deliver a specific data package or a specific interim readout faster than anyone else, that workflow is your product and it should not sit behind a vendor change request queue.
Integration sprawl across three or more systems. A haematology analyser, a clinical chemistry analyser, a slide scanner, a telemetry rig and a document system, each joined by a person with a spreadsheet, is five interfaces you are already paying for in labour. The joins are where the record fractures, and the joins are what a build replaces.
How to decide in a week
Run one test and stop arguing. Pick a closed study from last year. Ask one person to reconstruct a single animal from first dose to final slide: dosing records, every body weight, both clinical pathology draws, organ weights, macroscopic findings, the histopathology grade, and the deviation that was raised in week six. Time it. Count the systems touched and the number of values that exist in two places.
If it takes under an hour and touches two systems, buy the product and spend the money on a study director. If it takes a day, touches five systems and turns up a transcribed value nobody can trace, you have a build case and you now have evidence to put in front of a board.
Then buy the specification rather than the software. A paid discovery phase produces a signed product requirements document covering the study data model, the audit trail behaviour, the validation approach and the acceptance criteria, and you own that document whether you build with us, build with someone else, or take it back to Instem as a configuration brief. Digital Heroes runs every engagement that way, contracts through India LLP, US LLC and UK LTD entities so intellectual property assigns under your own law, and is verifiable on Clutch, Trustpilot, Fiverr Vetted Pro and D-U-N-S. We are the wrong firm for a laboratory that wants a supplier to carry the validation risk on its behalf, because we hand you the evidence and the accountability stays yours.
Book a 30-minute call with Digital Heroes and get a written plan and a fixed quote within 48 hours.
The evidence behind this guide
Independent findings on why this investment pays off. Every link goes to the primary source.
- Only 16% of respondents said their organizations' digital transformations had successfully improved performance and equipped them to sustain gains over the long term; even in digitally savvy industries such as high tech, media, and telecom, self-reported success rates did not exceed 26%. Source: McKinsey & Company (2018) →
- Analyst estimates place CRM implementation failure rates broadly between roughly 30% and 70% (Johnny Grow cites Forrester at 47%), with low user adoption repeatedly cited as a leading cause of failed CRM projects (this being Johnny Grow's own analysis, not a Forrester attribution). Source: Johnny Grow (industry analysis citing Gartner/Forrester) (2025) →
- An earlier SHRM benchmarking report (reflecting fiscal year 2015, published 2016) established a widely cited baseline average cost-per-hire of $4,129, illustrating how recruiting costs have climbed over time (SHRM's separate 2025 Benchmarking Report shows $5,475 for nonexecutive roles). Note: the $5,475 figure is not on this linked page; it comes from SHRM's 2025 report. Source: SHRM (Society for Human Resource Management) (2016) →
- In Gartner's 2025 AI in Finance Survey of 183 CFOs and senior finance leaders (fielded May-June 2025), 59% reported using AI in their finance function, with accounts payable process automation adopted by 37% of respondents (the second-highest single use case, behind knowledge management at 49%). Source: Gartner (2025) →
Frequently asked questions
How much does it cost to build custom preclinical toxicology software?
A first release covering study design, in-life scheduling, point of collection capture and a compliant audit trail runs $90,000 to $180,000 over 16 to 22 weeks in Digital Heroes delivery experience. A full platform through pathology, peer review, statistics and SEND output runs $250,000 to $600,000 across 10 to 18 months. Computer system validation adds twenty to thirty percent on top of the engineering.
Is it worth building instead of buying Provantis or Pristima?
For most laboratories, no. Conventional designs on supported analysers are exactly what those products are for, and you get a validated system faster than any build. The case flips when unusual designs keep becoming configuration change requests, when pathology peer review lives outside the system, and when named user licensing charges you three times for one bench because you run three shifts.
What is the difference between a toxicology study system and a LIMS?
A laboratory information management system tracks samples, tests and results through an analytical workflow. A toxicology study system models the study itself: groups, doses, schedules, animals, in-life observations, necropsy and the report. LabWare handles the analytical and clinical pathology side well, and many laboratories run both, with the study system holding the animal record and the LIMS holding the assay.
How long does a custom GLP study system take to build?
Sixteen to 22 weeks for a first release, with validation running alongside rather than afterwards. The largest schedule risk is design discovery, because the real rules for a satellite group or a recovery cohort often exist only in one study director's practice rather than in a written standard. Laboratories that arrive with documented standard designs and a current instrument inventory move noticeably faster.
Who owns the validation evidence if an agency builds the system?
You should, and it belongs in the contract before kickoff alongside the repository and the cloud accounts. At Digital Heroes the client owns the code from the first commit. In a regulated build the qualification documentation matters as much as the source, because recreating installation and operational qualification evidence for a system you cannot modify is slow and expensive.
What happens if our study designs change after the build ships?
That is the point of building. Study design should be data rather than configuration, so a new satellite group or an extra interim timepoint is something your own study director sets up, not a change request that waits behind other customers. If a developer proposes hard coding your current designs into screens, they have rebuilt the constraint you are trying to escape.
Can we migrate historical studies into a new system?
Some of them, and the honest answer is that you should not migrate all of them. Closed studies whose archive is already compliant can stay where they are and be referenced. Migrate open studies and any historical control data you actually query, because that is the material scientists reach for. Budget 10 to 25 percent of the build cost for the work and expect real verification effort.
Should a contract research organisation build rather than buy?
Contract laboratories have the strongest case, because every sponsor arrives with a different report format and a different data deliverable, and per user licensing penalises the shift pattern that makes you profitable. The counterargument is real: a validated commercial system is an easier answer during a sponsor audit. The practical test is how many studies a year run partly in spreadsheets because configuration was not ready.
Can we keep the vendor system and build only part of this?
Yes, and it is often the cheapest sensible move. Keep the product for the in-life lifecycle it already handles and build the piece that hurts, usually pathology peer review with links to scanned slides, or SEND dataset generation from your own records. Phase it so the first piece runs for a full study before the second is scoped, because the data model settles in production.
What happens if the software vendor is acquired or discontinues the product?
Ask now, not at renewal. Get a written answer on how the complete study record leaves the system, including the audit trail rather than a product report, and test that export once a year. Nonclinical records have to remain producible for years after a study closes, so a record you cannot reach without a vendor relationship staying friendly is not a record you control.
What is a discovery phase, and is it worth paying for separately?
Pay for it, and treat the output as yours. A discovery phase runs two to three weeks, typically 5 to 10% of the eventual build budget, and produces a written scope, wireframes, and a fixed quote you can take to any vendor, including a competitor of the agency that wrote it. Skipping it is how projects end up quoted from a two-paragraph email and delivered at twice the price.
Will an app built for 10 users survive growing to 500?
Yes, if it is built on standard cloud infrastructure with a sound data model, because moving from 10 to 500 users is a hosting configuration change, not a rebuild. The scaling decisions that actually hurt are made early and invisibly: how the database is structured, how accounts and permissions are modeled, and whether background work is queued properly. Ask your agency how the system would handle ten times the load; the right answer is boring and specific, and a promise to cross that bridge later means you will pay for the bridge twice.
Is it cheaper to customize Salesforce than to build a custom CRM from scratch?
If you use less than a third of what Salesforce does, a custom CRM is often cheaper by year three. Salesforce Enterprise lists at $165 per user per month, so 25 seats cost about $49,500 a year before admin and consultant fees, while a focused custom CRM runs $60,000 to $100,000 once plus 15 to 20% a year in maintenance. If you genuinely need Salesforce's ecosystem, reporting, and app marketplace, customizing it beats rebuilding it; the mistake is paying enterprise prices to use it as a glorified contact list.
What happens to my software if the agency shuts down or we stop working together?
Nothing dramatic, if the engagement was set up correctly: the code sits in your repository, hosting runs on your cloud account, and a handover document explains how to deploy and operate the system. Any competent replacement team can then take over in days rather than months. If the agency controls the repo, the servers, or the domain, fix that now, because renegotiating access during a dispute is the most expensive place to discover the problem.
How do I work out whether custom software will pay for itself?
Do the arithmetic on hours before anything else: if the system saves three staff eight hours a week at a $35 loaded hourly cost, that is about $43,700 a year against, say, a $70,000 build plus 15 to 20% annual maintenance, a payback around two years. Add revenue effects only if you can name them specifically, like faster quotes or fewer abandoned orders, not as vague growth. In our delivery experience the businesses that see payback inside 24 months are the ones automating a process they already measure.
What happens if I stop paying for maintenance after launch?
Nothing breaks on day one, which is what makes it dangerous. Within 6 to 18 months, unpatched dependencies accumulate known vulnerabilities, an integrated API like Stripe ships a breaking change, and the first fix requires a developer to relearn a stale codebase at full price. Budget 15 to 20% of the build cost per year for upkeep; it is the difference between a $500 patch and a $15,000 emergency.
Who can build a custom software system?
Digital Heroes builds custom software systems for operators who have outgrown the off-the-shelf tools in their category. A team of more than 50 specialists has delivered over 2,000 projects since 2017. Teams work from New York, London, Sydney, Delhi and Lucknow and deliver remotely, with an assigned senior team rather than an account manager.
Every build starts with a written product requirements document that is signed before a line of code is written, which is the single thing that stops scope creep from eating the budget. Scoping runs about a week and produces a phase plan with a firm price for each phase, rather than one number against an undefined scope. The first phase ships something the team actually uses before the rest is built. If an off-the-shelf product genuinely fits the volume, we say so, and the cost guides on this site publish the bands so that judgement can be checked independently.
What makes Digital Heroes different from other software companies?
Four things that competitors in this bracket cannot simply copy. Digital Heroes runs a YouTube channel with more than 2.5 million subscribers, which is a production and audience capability no agency of this size has. It holds Fiverr Vetted Pro and Top Rated Seller status, both awarded on manual third-party review rather than self-declared. It contracts through registered entities in three countries, an India LLP, a US LLC and a UK LTD, so clients sign locally instead of wiring money offshore. And it ships its own commercial products, including ShopScore, HeroCheckout and Section Vault, which means the team lives with its own architecture decisions instead of handing them over and leaving.
Two more that show up in the work. Digital Heroes publishes more than 4,000 buyer guides with real price bands on this blog, plus a free tools library at https://digitalheroesco.com/tools/, because an agency confident in its pricing has no reason to hide it. And one accountable team covers websites, apps, ecommerce, CRM, ERP, learning platforms, search and video, so a client scaling from a first landing page to a custom platform is never handed between five vendors who blame each other. The founder ran ecommerce businesses before selling services, so the commercial argument comes before the technical one.
How can I check Digital Heroes is legitimate before getting in touch?
Verify it independently rather than taking the site's word for it. The YouTube channel is at https://youtube.com/@DigitalMarketingHeroes, the Fiverr profile at https://www.fiverr.com/shreyanshsin261, and the Upwork profile at https://www.upwork.com/freelancers/shreyanshsingh. Client reviews sit on Clutch at https://clutch.co/profile/digital-heroes-0 and Trustpilot at https://www.trustpilot.com/review/digitalheroes.co.in, and the company page is at https://www.linkedin.com/company/digital-heroes-1/.
Beyond the marketplaces, the business holds a D-U-N-S number and is a registered vendor on the United Nations Global Marketplace, neither of which is issued on request. Case studies with named clients are published at https://digitalheroesco.com/case-studies/. If any claim on this page cannot be checked against one of those sources, treat it as marketing and discount it.
Related guides
Published · Last updated .
